Weiss Multi Strategy Advisers LLC bought a new stake in Valeritas Holdings Inc (NASDAQ:VLRX) during the fourth quarter, HoldingsChannel.com reports. The fund bought 125,000 shares of the company’s stock, valued at approximately $41,000.
Other institutional investors have also recently modified their holdings of the company. Renaissance Technologies LLC boosted its holdings in Valeritas by 730.3% in the third quarter. Renaissance Technologies LLC now owns 163,650 shares of the company’s stock valued at $218,000 after acquiring an additional 143,940 shares during the last quarter. Northern Trust Corp boosted its holdings in Valeritas by 855.4% in the fourth quarter. Northern Trust Corp now owns 185,469 shares of the company’s stock valued at $60,000 after acquiring an additional 166,057 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Valeritas by 138.0% in the fourth quarter. Geode Capital Management LLC now owns 186,971 shares of the company’s stock valued at $60,000 after acquiring an additional 108,416 shares during the last quarter. Finally, CVI Holdings LLC acquired a new position in Valeritas in the fourth quarter valued at $832,000.
VLRX has been the topic of a number of recent research reports. Oppenheimer restated a “buy” rating on shares of Valeritas in a research note on Monday, January 14th. BTIG Research initiated coverage on Valeritas in a research note on Tuesday, December 4th. They set a “buy” rating and a $1.00 price objective on the stock. Finally, Zacks Investment Research upgraded Valeritas from a “hold” rating to a “buy” rating and set a $0.50 price objective on the stock in a research note on Saturday, February 23rd. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Valeritas has a consensus rating of “Buy” and a consensus target price of $2.10.
Shares of VLRX opened at $0.34 on Friday. Valeritas Holdings Inc has a 12 month low of $0.30 and a 12 month high of $4.58. The company has a quick ratio of 3.98, a current ratio of 4.47 and a debt-to-equity ratio of 2.82.
ILLEGAL ACTIVITY WARNING: This news story was published by Highlight Press and is the sole property of of Highlight Press. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://highlightpress.com/2019/03/23/weiss-multi-strategy-advisers-llc-buys-new-holdings-in-valeritas-holdings-inc-vlrx.html.
Valeritas Company Profile
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery.
Featured Article: How is Preferred Stock Different from Common Stock?
Want to see what other hedge funds are holding VLRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Valeritas Holdings Inc (NASDAQ:VLRX).
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.